[English] 日本語
Yorodumi
- PDB-2zvw: Crystal structure of Proliferating cell nuclear antigen 2 and Sho... -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 2zvw
TitleCrystal structure of Proliferating cell nuclear antigen 2 and Short peptide from human P21
Components
  • Cyclin-dependent kinase inhibitor 1
  • Proliferating cell nuclear antigen 2
KeywordsDNA BINDING PROTEIN / protein-peptide complex / DNA replication / DNA-binding / Nucleus
Function / homology
Function and homology information


cyclin-dependent protein kinase activating kinase activity / cellular response to cell-matrix adhesion / negative regulation of cyclin-dependent protein kinase activity / negative regulation of cardiac muscle tissue regeneration / FOXO-mediated transcription of cell cycle genes / TFAP2 (AP-2) family regulates transcription of cell cycle factors / negative regulation of phosphorylation / intestinal epithelial cell maturation / tissue regeneration / PCNA-p21 complex ...cyclin-dependent protein kinase activating kinase activity / cellular response to cell-matrix adhesion / negative regulation of cyclin-dependent protein kinase activity / negative regulation of cardiac muscle tissue regeneration / FOXO-mediated transcription of cell cycle genes / TFAP2 (AP-2) family regulates transcription of cell cycle factors / negative regulation of phosphorylation / intestinal epithelial cell maturation / tissue regeneration / PCNA-p21 complex / regulation of cell cycle G1/S phase transition / import into nucleus / Transcriptional regulation by RUNX2 / negative regulation of DNA biosynthetic process / cyclin-dependent protein serine/threonine kinase inhibitor activity / response to arsenic-containing substance / positive regulation of programmed cell death / Transcriptional activation of cell cycle inhibitor p21 / oncogene-induced cell senescence / AKT phosphorylates targets in the cytosol / RUNX3 regulates CDKN1A transcription / : / stress-induced premature senescence / response to corticosterone / molecular function inhibitor activity / cellular response to UV-B / regulation of cyclin-dependent protein serine/threonine kinase activity / response to aldosterone / negative regulation of G1/S transition of mitotic cell cycle / STAT5 activation downstream of FLT3 ITD mutants / p53-Dependent G1 DNA Damage Response / DNA polymerase processivity factor activity / protein kinase inhibitor activity / Constitutive Signaling by AKT1 E17K in Cancer / Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) / mitotic G2 DNA damage checkpoint signaling / regulation of G1/S transition of mitotic cell cycle / regulation of DNA replication / negative regulation of vascular associated smooth muscle cell proliferation / keratinocyte proliferation / replicative senescence / positive regulation of protein kinase activity / response to X-ray / intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator / response to hyperoxia / TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest / animal organ regeneration / error-prone translesion synthesis / Regulation of MITF-M-dependent genes involved in cell cycle and proliferation / Cyclin E associated events during G1/S transition / negative regulation of protein phosphorylation / : / Cyclin A:Cdk2-associated events at S phase entry / cyclin-dependent protein kinase holoenzyme complex / protein serine/threonine kinase binding / keratinocyte differentiation / regulation of G2/M transition of mitotic cell cycle / positive regulation of B cell proliferation / Signaling by FLT3 fusion proteins / protein sequestering activity / cyclin binding / intrinsic apoptotic signaling pathway / cellular response to amino acid starvation / negative regulation of protein binding / molecular function activator activity / positive regulation of DNA replication / cellular response to ionizing radiation / wound healing / cellular response to gamma radiation / negative regulation of cell growth / DNA Damage/Telomere Stress Induced Senescence / SCF(Skp2)-mediated degradation of p27/p21 / G1/S transition of mitotic cell cycle / response to toxic substance / Transcriptional regulation of granulopoiesis / protein import into nucleus / positive regulation of fibroblast proliferation / Cyclin D associated events in G1 / positive regulation of reactive oxygen species metabolic process / The role of GTSE1 in G2/M progression after G2 checkpoint / cellular senescence / KEAP1-NFE2L2 pathway / Signaling by ALK fusions and activated point mutants / Neddylation / heart development / cellular response to heat / Senescence-Associated Secretory Phenotype (SASP) / fibroblast proliferation / Interleukin-4 and Interleukin-13 signaling / in utero embryonic development / Ras protein signal transduction / DNA replication / regulation of cell cycle / nuclear body / response to xenobiotic stimulus / negative regulation of cell population proliferation / negative regulation of gene expression / ubiquitin protein ligase binding / DNA damage response / protein-containing complex binding
Similarity search - Function
Cyclin-dependent kinase inhibitor 1 / Cyclin-dependent kinase inhibitor domain / Cyclin-dependent kinase inhibitor domain superfamily / Cyclin-dependent kinase inhibitor / Box / Proliferating Cell Nuclear Antigen / Proliferating Cell Nuclear Antigen - #10 / Proliferating cell nuclear antigen signature 2. / Proliferating cell nuclear antigen, PCNA, conserved site / Proliferating cell nuclear antigen signature 1. ...Cyclin-dependent kinase inhibitor 1 / Cyclin-dependent kinase inhibitor domain / Cyclin-dependent kinase inhibitor domain superfamily / Cyclin-dependent kinase inhibitor / Box / Proliferating Cell Nuclear Antigen / Proliferating Cell Nuclear Antigen - #10 / Proliferating cell nuclear antigen signature 2. / Proliferating cell nuclear antigen, PCNA, conserved site / Proliferating cell nuclear antigen signature 1. / Proliferating cell nuclear antigen, PCNA / Proliferating cell nuclear antigen, PCNA, N-terminal / Proliferating cell nuclear antigen, PCNA, C-terminal / Proliferating cell nuclear antigen, N-terminal domain / Proliferating cell nuclear antigen, C-terminal domain / : / Alpha Beta
Similarity search - Domain/homology
Cyclin-dependent kinase inhibitor 1 / Proliferating cell nuclear antigen 2
Similarity search - Component
Biological speciesArabidopsis thaliana (thale cress)
MethodX-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 2.5 Å
AuthorsStrzalka, W. / Oyama, T. / Tori, K. / Morikawa, K.
CitationJournal: Protein Sci. / Year: 2009
Title: Crystal structures of the Arabidopsis thaliana proliferating cell nuclear antigen 1 and 2 proteins complexed with the human p21 C-terminal segment
Authors: Strzalka, W. / Oyama, T. / Tori, K. / Morikawa, K.
History
DepositionNov 21, 2008Deposition site: PDBJ / Processing site: PDBJ
Revision 1.0Jun 2, 2009Provider: repository / Type: Initial release
Revision 1.1Jul 13, 2011Group: Version format compliance
Revision 1.2Nov 1, 2023Group: Data collection / Database references ...Data collection / Database references / Derived calculations / Refinement description
Category: chem_comp_atom / chem_comp_bond ...chem_comp_atom / chem_comp_bond / database_2 / pdbx_initial_refinement_model / struct_ref_seq_dif / struct_site
Item: _database_2.pdbx_DOI / _database_2.pdbx_database_accession ..._database_2.pdbx_DOI / _database_2.pdbx_database_accession / _struct_ref_seq_dif.details / _struct_site.pdbx_auth_asym_id / _struct_site.pdbx_auth_comp_id / _struct_site.pdbx_auth_seq_id

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
A: Proliferating cell nuclear antigen 2
B: Proliferating cell nuclear antigen 2
C: Proliferating cell nuclear antigen 2
D: Proliferating cell nuclear antigen 2
E: Proliferating cell nuclear antigen 2
F: Proliferating cell nuclear antigen 2
G: Proliferating cell nuclear antigen 2
H: Proliferating cell nuclear antigen 2
I: Cyclin-dependent kinase inhibitor 1
J: Cyclin-dependent kinase inhibitor 1
K: Cyclin-dependent kinase inhibitor 1
L: Cyclin-dependent kinase inhibitor 1
M: Cyclin-dependent kinase inhibitor 1
N: Cyclin-dependent kinase inhibitor 1
O: Cyclin-dependent kinase inhibitor 1
P: Cyclin-dependent kinase inhibitor 1
hetero molecules


Theoretical massNumber of molelcules
Total (without water)265,58323
Polymers264,91116
Non-polymers6727
Water2,936163
1
A: Proliferating cell nuclear antigen 2
B: Proliferating cell nuclear antigen 2
C: Proliferating cell nuclear antigen 2
I: Cyclin-dependent kinase inhibitor 1
J: Cyclin-dependent kinase inhibitor 1
K: Cyclin-dependent kinase inhibitor 1
hetero molecules


Theoretical massNumber of molelcules
Total (without water)99,6309
Polymers99,3426
Non-polymers2883
Water905
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Buried area8860 Å2
ΔGint-89 kcal/mol
Surface area34170 Å2
MethodPISA
2
D: Proliferating cell nuclear antigen 2
E: Proliferating cell nuclear antigen 2
F: Proliferating cell nuclear antigen 2
L: Cyclin-dependent kinase inhibitor 1
M: Cyclin-dependent kinase inhibitor 1
N: Cyclin-dependent kinase inhibitor 1
hetero molecules


Theoretical massNumber of molelcules
Total (without water)99,6309
Polymers99,3426
Non-polymers2883
Water905
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Buried area9030 Å2
ΔGint-94 kcal/mol
Surface area34110 Å2
MethodPISA
3
G: Proliferating cell nuclear antigen 2
O: Cyclin-dependent kinase inhibitor 1

G: Proliferating cell nuclear antigen 2
O: Cyclin-dependent kinase inhibitor 1

G: Proliferating cell nuclear antigen 2
O: Cyclin-dependent kinase inhibitor 1


Theoretical massNumber of molelcules
Total (without water)99,3426
Polymers99,3426
Non-polymers00
Water1086
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
crystal symmetry operation2_645-y+1,x-y-1,z1
crystal symmetry operation3_765-x+y+2,-x+1,z1
Buried area7890 Å2
ΔGint-50 kcal/mol
Surface area34690 Å2
MethodPISA
4
H: Proliferating cell nuclear antigen 2
P: Cyclin-dependent kinase inhibitor 1
hetero molecules

H: Proliferating cell nuclear antigen 2
P: Cyclin-dependent kinase inhibitor 1
hetero molecules

H: Proliferating cell nuclear antigen 2
P: Cyclin-dependent kinase inhibitor 1
hetero molecules


Theoretical massNumber of molelcules
Total (without water)99,6309
Polymers99,3426
Non-polymers2883
Water1086
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
crystal symmetry operation2_645-y+1,x-y-1,z1
crystal symmetry operation3_765-x+y+2,-x+1,z1
Buried area8820 Å2
ΔGint-91 kcal/mol
Surface area34410 Å2
MethodPISA
Unit cell
Length a, b, c (Å)223.693, 223.693, 200.876
Angle α, β, γ (deg.)90.00, 90.00, 120.00
Int Tables number146
Space group name H-MH3

-
Components

#1: Protein
Proliferating cell nuclear antigen 2 / PCNA 2


Mass: 30334.625 Da / Num. of mol.: 8
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Arabidopsis thaliana (thale cress) / Plasmid: pET15b / Production host: Escherichia coli (E. coli) / Strain (production host): BL21(DE3) / References: UniProt: Q9ZW35
#2: Protein/peptide
Cyclin-dependent kinase inhibitor 1 / p21 / CDK-interacting protein 1 / Melanoma differentiation-associated protein 6 / MDA-6


Mass: 2779.233 Da / Num. of mol.: 8 / Fragment: UNP residues 139-160 / Source method: obtained synthetically / Details: A synthetic fragment 139-160 of the human p21/WAF1 / References: UniProt: P38936
#3: Chemical
ChemComp-SO4 / SULFATE ION


Mass: 96.063 Da / Num. of mol.: 7 / Source method: obtained synthetically / Formula: SO4
#4: Water ChemComp-HOH / water


Mass: 18.015 Da / Num. of mol.: 163 / Source method: isolated from a natural source / Formula: H2O

-
Experimental details

-
Experiment

ExperimentMethod: X-RAY DIFFRACTION / Number of used crystals: 1

-
Sample preparation

CrystalDensity Matthews: 3.65 Å3/Da / Density % sol: 66.31 %
Crystal growTemperature: 293 K / Method: vapor diffusion, hanging drop / pH: 4.5
Details: 100mM citric acid, 1.8M ammonium salfate, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K

-
Data collection

DiffractionMean temperature: 100 K
Diffraction sourceSource: SYNCHROTRON / Site: SPring-8 / Beamline: BL38B1 / Wavelength: 1 Å
DetectorType: RIGAKU JUPITER 210 / Detector: CCD / Date: Oct 13, 2008
RadiationMonochromator: Fixed exit Si 111 double crystal monochromator
Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray
Radiation wavelengthWavelength: 1 Å / Relative weight: 1
ReflectionResolution: 2.5→50 Å / Num. obs: 129598 / % possible obs: 99.9 % / Observed criterion σ(I): 0 / Redundancy: 5.9 % / Biso Wilson estimate: 45.1 Å2 / Rsym value: 0.047
Reflection shellResolution: 2.5→2.59 Å / Redundancy: 5.9 % / Rmerge(I) obs: 0.184 / Num. unique all: 129598 / % possible all: 100

-
Processing

Software
NameVersionClassification
CNS1.1refinement
HKL-2000data collection
HKL-2000data reduction
HKL-2000data scaling
CNSphasing
RefinementMethod to determine structure: MOLECULAR REPLACEMENT
Starting model: PDB ENTRY 1AXC

1axc


Resolution: 2.5→36.69 Å / Rfactor Rfree error: 0.003 / Data cutoff high absF: 211911.52 / Data cutoff low absF: 0 / Isotropic thermal model: RESTRAINED / Cross valid method: THROUGHOUT / σ(F): 0 / Stereochemistry target values: Engh & Huber
RfactorNum. reflection% reflectionSelection details
Rfree0.261 6499 5 %RANDOM
Rwork0.234 ---
obs0.234 128983 99.4 %-
Solvent computationSolvent model: FLAT MODEL / Bsol: 31.2552 Å2 / ksol: 0.353001 e/Å3
Displacement parametersBiso mean: 44.8 Å2
Baniso -1Baniso -2Baniso -3
1-3.27 Å27.01 Å20 Å2
2--3.27 Å20 Å2
3----6.55 Å2
Refine analyze
FreeObs
Luzzati coordinate error0.39 Å0.33 Å
Luzzati d res low-5 Å
Luzzati sigma a0.38 Å0.27 Å
Refinement stepCycle: LAST / Resolution: 2.5→36.69 Å
ProteinNucleic acidLigandSolventTotal
Num. atoms16392 0 35 163 16590
Refine LS restraints
Refine-IDTypeDev idealDev ideal target
X-RAY DIFFRACTIONc_bond_d0.008
X-RAY DIFFRACTIONc_bond_d_na
X-RAY DIFFRACTIONc_bond_d_prot
X-RAY DIFFRACTIONc_angle_d
X-RAY DIFFRACTIONc_angle_d_na
X-RAY DIFFRACTIONc_angle_d_prot
X-RAY DIFFRACTIONc_angle_deg1.3
X-RAY DIFFRACTIONc_angle_deg_na
X-RAY DIFFRACTIONc_angle_deg_prot
X-RAY DIFFRACTIONc_dihedral_angle_d26.8
X-RAY DIFFRACTIONc_dihedral_angle_d_na
X-RAY DIFFRACTIONc_dihedral_angle_d_prot
X-RAY DIFFRACTIONc_improper_angle_d1.17
X-RAY DIFFRACTIONc_improper_angle_d_na
X-RAY DIFFRACTIONc_improper_angle_d_prot
X-RAY DIFFRACTIONc_mcbond_it1.681.5
X-RAY DIFFRACTIONc_mcangle_it2.842
X-RAY DIFFRACTIONc_scbond_it2.232
X-RAY DIFFRACTIONc_scangle_it3.382.5
LS refinement shellResolution: 2.5→2.66 Å / Rfactor Rfree error: 0.01 / Total num. of bins used: 6
RfactorNum. reflection% reflection
Rfree0.337 1090 5.1 %
Rwork0.286 20184 -
obs--98.4 %
Xplor file
Refine-IDSerial noParam fileTopol file
X-RAY DIFFRACTION1protein_rep.paramprotein.top
X-RAY DIFFRACTION2water.paramwater.top
X-RAY DIFFRACTION3ion.paramion.top

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242)：Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more